BioCentury
ARTICLE | Company News

Allenex, CareDx deal

April 25, 2016 7:00 AM UTC

CareDx acquired fellow transplant diagnostic company Allenex. For each Allenex share held, majority shareholders received 0.01458 CareDx shares, SEK1.191 in cash and a separate cash payment of SEK0.540, which is deferred until March 31, 2017. Majority shareholders held about 78% of the company. The remaining shareholders received either SEK2.50 per share held or a combination of SEK1.731 in cash and 0.01458 CareDx share per Allenex share held. In its initial December offer, CareDx said the total purchase price was about $35 million in cash and stock. ...